AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial

CONTEXT AND OBJECTIVE: Prader-Willi syndrome (PWS) is characterized by early-onset hyperphagia and increased circulating levels of the orexigenic Acylated Ghrelin (AG) hormone with a relative deficit of Unacylated Ghrelin (UAG). AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Allas, Soraya, Caixàs, Assumpta, Poitou, Christine, Coupaye, Muriel, Thuilleaux, Denise, Lorenzini, Françoise, Diene, Gwenaëlle, Crinò, Antonino, Illouz, Frédéric, Grugni, Graziano, Potvin, Diane, Bocchini, Sarah, Delale, Thomas, Abribat, Thierry, Tauber, Maithé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761957/
https://www.ncbi.nlm.nih.gov/pubmed/29320575
http://dx.doi.org/10.1371/journal.pone.0190849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761957/
https://www.ncbi.nlm.nih.gov/pubmed/29320575
http://dx.doi.org/10.1371/journal.pone.0190849

Ejemplares similares